Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02340156
What this trial is testing

Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma

Who this might be right for
RECURRENT GLIOBLASTOMA
SynerGene Therapeutics, Inc. 1
Very early researchActive Not RecruitingNCT05023551
What this trial is testing

Study of DSP-0390 in Patients With Recurrent High-Grade Glioma

Who this might be right for
High Grade GliomaGlioblastoma Multiforme
Sumitomo Pharma America, Inc. 39
Testing effectiveness (Phase 2)Ended earlyNCT03119064
What this trial is testing

BrUOG 329 Onivyde & Metronomic Temozolomide in Recurrent Glioblastoma

Who this might be right for
Glioblastoma MultiformeGlioblastomaGBM
Brown University 12
Testing effectiveness (Phase 2)Study completedNCT05183204
What this trial is testing

Paxalisib With a High Fat, Low Carb Diet and Metformin for Glioblastoma

Who this might be right for
Glioblastoma
Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)Study completedNCT00541138
What this trial is testing

Tamoxifen, Carboplatin, and Topotecan in Treating Patients With CNS Metastases or Recurrent Brain or Spinal Cord Tumors

Who this might be right for
Brain and Central Nervous System TumorsMetastatic CancerUnspecified Adult Solid Tumor, Protocol Specific
City of Hope Medical Center 50
Testing effectiveness (Phase 2)Study completedNCT03291314
What this trial is testing

Clinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma (WHO-Grade IV Glioma)
Universitair Ziekenhuis Brussel 52
Early research (Phase 1)Study completedNCT02718443
What this trial is testing

VXM01 Phase I Pilot Study in Patients With Operable Recurrence of a Glioblastoma

Who this might be right for
Glioblastoma
Vaximm GmbH 14
Testing effectiveness (Phase 2)Ended earlyNCT01011231
What this trial is testing

Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Imaging (MRI) Spectroscopy for Recurrent Glioma

Who this might be right for
Glioblastoma
University of California, San Francisco 1
Testing effectiveness (Phase 2)Study completedNCT04704154
What this trial is testing

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

Who this might be right for
Solid Tumors
Bayer 175
Testing effectiveness (Phase 2)Study completedNCT00498927
What this trial is testing

Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 47
Early research (Phase 1)Not Yet RecruitingNCT07455045
What this trial is testing

A Phase I Study of FZ-AD005 in Patients With High-Grade Glioma (HGG)

Who this might be right for
High Grade Glioma (III or IV)Diffuse Midline Glioma (DMG)Glioblastoma (GBM)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. 40
Testing effectiveness (Phase 2)UnknownNCT04888611
What this trial is testing

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Huashan Hospital 40
Early research (Phase 1)WithdrawnNCT06501911
What this trial is testing

Bicalutamide With Brain Re-irradiation to Treat Recurrent/Progressive High Grade Glioma

Who this might be right for
Recurrent GlioblastomaRecurrent High-grade Glioma
University of Nebraska
Testing effectiveness (Phase 2)Study completedNCT02717962
What this trial is testing

Study of VAL-083 in Patients With MGMT Unmethylated, Bevacizumab-naive Glioblastoma in the Adjuvant or Recurrent Setting

Who this might be right for
GliomaGlioblastomaGlioblastoma Multiforme+2 more
Kintara Therapeutics, Inc. 118
Early research (Phase 1)Study completedNCT00030108
What this trial is testing

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+7 more
National Institutes of Health Clinical Center (CC) 30
Testing effectiveness (Phase 2)Study completedNCT00586508
What this trial is testing

Trial of Enzastaurin and Bevacizumab in Participants With Recurrent Malignant Gliomas

Who this might be right for
Recurrent Glioblastoma
Eli Lilly and Company 81
Testing effectiveness (Phase 2)Looking for participantsNCT04590664
What this trial is testing

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Who this might be right for
GlioblastomaRecurrent Glioblastoma
Emory University 24
Testing effectiveness (Phase 2)Ended earlyNCT02942264
What this trial is testing

Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma

Who this might be right for
Brain TumorAstrocytomaAstroglioma+2 more
National Cancer Institute (NCI) 53
Testing effectiveness (Phase 2)Looking for participantsNCT06161519
What this trial is testing

PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications

Who this might be right for
GliomaMedulloblastomaEpendymoma+1 more
National Cancer Institute (NCI) 146
Early research (Phase 1)Ended earlyNCT00003567
What this trial is testing

Gene Therapy and Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 8
Next Page